Article

Family history primary factor in development of AMD

Numerous factors have been studied to determine an association with the development of age-related macular degeneration (AMD), according to Barbara Klein, MD, of the University of Wisconsin, Madison.

May 2 - Fort Lauderdale, FL - Numerous factors have been studied to determine an association with the development of age-related macular degeneration (AMD), according to Barbara Klein, MD, of the University of Wisconsin, Madison.

A very important factor for the most common form of AMD is age. Most studies show an increase in severity and frequency of AMD lesions with age in patients 75 years of age and older compared with younger individuals.

Other risk factors, such as sex, blood pressure, and cigarette smoking, have been studied but the results are less definitive.

By far, the factor that has the strongest correlation with the development of AMD is family history, according to Dr. Klein. "It has become apparent that this familial risk is at least in part the result of genetic factors," she said at the annual meeting of the Association for Research in Vision and Ophthalmology.

Several investigators, she pointed out, have identified candidate regions in a variety of places in the genome. For example, in the Beaver Dam study, in which 602 families participated, analysis of the CFH gene locus is pending, but linkage has been to 1p35 and 15q22.

"The influence of any particular gene may be dependent on the effect of other genes and the environment. An approach that embraces personal and environmental factors and modifier genes is likely to be the most informative way to find out more about AMD," she said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.